BusinessFirst Comprehensive Clinical Site Initiation Benchmark, Developed by Tufts Center for the Study of Drug Development, Finds Study Startup Is Lengthy and InefficientBy Nasdaq OMXMar 7, 2018, 2:01 PM UTC
BusinesseClinical Data Volume and Diversity Pose Increasing Challenges and Delays, According to the Tufts Center for the Study of Drug DevelopmentBy Nasdaq OMXJan 9, 2018, 2:01 PM UTC
